t is clinically important to define the effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) in human arteries in vivo because hyperlipidemia is a risk factor for atherosclerotic vascular disease. Several large-scale clinical trials have demonstrated that statins prevent the development of coronary events and reduce mortality, in addition to having a hypolipidemic effect. In the ASAP trial (Atorvastatin vs Simvastatin on Atherosclerosis Progression) it was reported that aggressive cholesterol lowering with high-dose atorvastatin in familial hypercholesterolemia resulted in regression of carotid intima -media thickness (IMT), using B-mode ultrasound, over a treatment period of 2 years. 1 B-mode ultrasound is a useful tool for detecting minimal atherosclerotic changes in the walls of the carotid and femoral arteries and the technique has been widely standardized for the measurement of IMT because increases in the thickness of the intima and media of the carotid artery are associated with an increased risk of myocardial infarction and stroke in subjects without a history of cardiovascular disease. 2, 3 The effect of pravastatin on carotid atherosclerosis, as measured by B-mode ultrasound, was evaluated in the LIPID and KAPS studies. 4, 5 In both those studies, a significant reduction in the rate of carotid artery IMT progression was shown. Recently, ultrasonic tissue characterization of the carotid arteries with an integrated backscatter (IB) analysis was developed and is capable of identifying the high-risk group with systemic atherosclerosis. 6,7 Furthermore we reported that IB ultrasound accurately reflected the tissue characteristics of human carotid arterial plaques in a study in which IB values recorded in vivo precisely correlated with the IB values obtained just after excision at autopsy or the IB values after fixation. 8 There are a few studies that have used B-mode ultrasound to non-invasively evaluate the effect of statin therapy on carotid IMT, but there is no published information on evaluating the effects of statin therapy on the arterial wall by IB ultrasound.
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Currently, there are various types of statins that are effective in the treatment of hyperlipidemia and coronary artery disease, but their effects on medial sclerosis of arteries are unclear. The purpose of the present study was to use IB ultrasound to compare the effects of cerivastatin (C), which is lipophilic and has a strong anti-proliferative effect (APE) on smooth muscle cells (SMCs), with those of pravastatin (P), which is hydrophilic and has a weak effect. tients were either previously untreated or treated with other drugs except statins, but had total cholesterol concentrations remaining above 220 mg/dl. They were randomized to a statin-treatment group of cerivastatin (C: 0.3 mg/day, n=18), pravastatin (P: 20 mg/day, n=16) or a control group treated with diet only (D: n=14). Study patients were referred to a nutritionist for individual counseling and were also provided with a lifestyle-changing program that included smoking cessation. The protocol was approved by the institutional ethics committee, and informed consent was obtained from all patients before enrollment. There were no serious cardiovascular events including myocardial infarction, unstable angina, or death in any study group.
Five patients in C group, 4 in P group and 3 in D group did not complete the study (25%) because of relocation, non-compliance or side effects of the therapy, so 72 segments (right and left common carotid arteries in each patient) in 36 patients (C 13; P 12; D 11) with hyperlipidemia (15 males, 21 females; age range, 46-77 years, 64±9 years old) were studied. We evaluated the incidence of other coronary risk factors in each patient including high blood pressure, diabetes mellitus, smoking status and myocardial infarction (Table 1 ). In addition, we measured the IB values of 34 segments of the carotid arteries in 34 patients (age range, 14-87 years; 17 males, 17 females) without coronary risk factors.
Study Protocol
We measured the IB values of one site in the media of the right common carotid arteries and one site in the media of the left common carotid arteries of each subject at baseline and after 6 months. At the same time, we measured IMT and arterial stiffness by conventional echo in the same segments. Furthermore, fasting plasma concentrations of total cholesterol (TC), low-density and high-density lipoprotein cholesterol (LDL-C, HDL-C) remnant-like particle cholesterol (RLP-C), lipoprotein (a) (Lp (a)), C-reactive protein (CRP) and matrix metalloproteinase-1 (MMP-1) were analyzed.
IB System Presets and Data Acquisition
The patients remained supine with the head tilted slightly to the contra-lateral side while transverse scans were performed between the middle of the bilateral common carotid arteries and the bifurcation of the external carotid artery and internal carotid artery. Conventional echo images and IB images were easily acquired at the bedside using a commercially available 2-dimensional (2-D) ultrasonic imaging system (Sonos 5500, Philips Medical Systems) using a 5-12 MHz transducer for all studies. The software provided with the system enabled the acquisition, storage and retrieval of a sequence of 2-D conventional and IB images, forming a continuous loop digital recording of 2 s (60 frames in 2 s). Off-line analysis of the 2-D IB images was performed by retrieving the previously stored data from the optical disk drive in the system. IB was calculated as the average power of the ultrasound backscatter signal from a small volume of tissue using the following formula measured in decibels (dB):
where V is the signal voltage from region of interest (ROI), V0 is the smallest signal voltage that the system can detect, and T is the integration interval.
In the present study, we used a square-shaped ROI that was 11×11 pixels (0.6×0.6 mm) and set the time gain compensation at 0 dB and the lateral gain compensation at 50 dB for each measurement. At these settings, the IB values of stainless steel in 0.9% saline at a distance of 1-2 cm from the transducer were 50 dB, which was within the dynamic range of the system.
ROI Setting and Correction of IB Values
The IB values in the anterior wall were excluded from the analysis because of erratic diffraction phenomena and the influence of angle dependency, so the IB evaluation was performed using the posterior arterial wall without plaque. IB values in the entire posterior wall of the arteries (an angle span of 30°between -15°and +15°) were measured. The IB values were determined by averaging the IB values from 10 sites continuously moving the ROI above the posterior arterial site. The IB values of the posterior arterial wall were corrected by subtracting the minimum IB values of the vessel lumen just above the posterior wall. 8 ROIs were set over the media without plaque in the ringlike IB images in combination with the anatomical information from the corresponding 2-D echo images. We defined the presence of plaque as an area where IMT was more than 1.6 mm.
Measurement of Stiffness Index
It has been reported that in conventional ultrasound studies the stiffness index (stiffness ) is a quantitative index of the elastic properties of large arteries. The stiffness is calculated from the measurement of blood pres- sure and arterial diameter 9 and is defined as:
where Ps is systolic pressure, Pd is diastolic pressure, Ds is the lumen diameter at systole, and Dd is the lumen diameter at diastole. The lumen diameter of the carotid arteries was measured in the same segment in which IB was measured. Blood pressure was measured in the brachial artery using a sphygmomanometer immediately after the ultrasound examinations.
Statistical Analysis
Numerical data are expressed as the mean ± SD. The significance of the differences between various parameters at baseline and after 6 months was tested using a Wilcoxon signed-rank test. The significance of the differences in stiffness at baseline and after 6 months was tested using Welch's t-test, because the variances were significantly different at baseline and after 6 months. The significance of the differences in each parameter among the C, P and D groups was tested using one-way analysis of variance, followed by post-hoc comparisons with Fisher's least significant difference test. Correlation among IB values, stiffness and age was tested by Pearson's correlation coefficient. A p-value <0.05 was considered to be significant.
Results

CRP and Lipid Parameters
Both the lipid parameters of patients and the non-invasively determined vascular parameters in each group, at baseline and 6 months, are shown in Table 2 . At baseline, lipid and lipoprotein concentrations did not differ between groups. After initiating statin therapy, the lipid profile significantly improved immediately, but remained unchanged in D group. In the P and C groups, respectively, total cho- Changes in the ultrasound parameters after statin therapy. The significance of the differences of each parameter among the C, P and the D group were tested using analysis of variance, followed by post-hoc comparisons with Fisher's least significant difference test. *p<0.05, **p<0.01. There was no effect of pravastatin on arterial medial properties assessed by the IB values and stiffness whereas cerivastatin was associated with improved IB values and stiffness .
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lesterol decreased by 20.2% (p<0.01) and 19.9% (p<0.01) after 6 months. LDL-C decreased by 27.0% (p<0.05) and by 31.3% (p<0.01), HDL-C increased by 5.5% (p<0.05) and by 12.9% (p<0.05) and RLP-C decreased by 27.9% (p<0.05) and by 36.8% (p<0.05). Lp (a) remained unchanged in each group. The CRP level significantly decreased from 0.30± 0.35 mg/dl to 0.17±0.15 mg/dl in the P group, and from 0.25±0.13 mg/dl to 0.18±0.20 mg/dl in the C group after 6 months. The MMP-1 level significantly decreased from 16.8±2.6 mg/dl to 10.3±2.9 mg/dl in the C group after 6 months.
Ultrasound Parameters
Baseline IB values and other characteristics and parameters were similar among the study groups (Table 3) . At baseline, no significant differences were found in the mean IMT, stiffness or corrected IB values of the carotid arteries in the 3 groups (P, C, D) (Fig 1) .
The IB values of the carotid arteries significantly decreased in the C group after 6 months (from 12.1±2.9 dB to 10.0±2.7 dB, p<0.01), but did not change significantly in the P or D group. Stiffness significantly decreased in the C group after 6 months (from 10.1±4.3 to 7.9±3.3, p<0.05), but did not change significantly in the P or D group. IMT did not change significantly in any group. In the C group, the relative change in IMT showed a regressive tendency compared with an increase in the P and D groups (Fig 2) . In the patients without coronary risk factors, IB values correlated with age (r=0.70, p<0.01) (Fig 3A) and stiffness (r= 0.67, p<0.01) (Fig 3B) . In addition, stiffness correlated with age (r=0.80, p<0.01) (Fig 3C) . In all 3 study groups (C, P and D), IB values weakly correlated with stiffness (r=0.51, p<0.01) (Fig 3D) .
Discussion
It is well known that medial sclerosis, consisting of the fragmentation of elastic fibers and collagen fibers and calcification, progresses in middle-sized arteries in patients with hyperlipidemia. It is reported that arterial stiffness is strongly associated with atherosclerosis at various sites in the vascular tree, 10 so it is clinically important to develop non-invasive techniques of evaluating medial sclerosis and the tissue characteristics of plaques. Arterial aging is defined as the age-related structural and functional changes in arteries and is recognized as thickening of the IMT in association with atherosclerotic plaques and decreased extensibility. The decreased extensibility is associated with structural changes in elastin and collagen fibers. There are several approaches to evaluating atherosclerosis, such as IMT, which is associated with atherosclerotic plaque formation, and arterial stiffness, which may correlated with the decreased extensibility of the arterial wall. 10, 11 However, it is clinically important to define the effect of statins in human arteries in vivo because hyperlipidemia is a risk factor for atherosclerotic vascular disease. We recently reported that the IB values of the carotid and femoral arteries accurately reflected histology, an evaluation that was not possible using conventional ultrasound. 8 
IB Values and Aging
There were significant correlations between the IB values of the carotid media and age (r=0.70, p<0.01) and stiffness (r=0.67, p<0.01) in the patients without coronary risk factors, which suggests that the IB values reflect the stiffness of the carotid arteries. However, arterial stiffness is influenced by many factors such as intimal plaque, IMT and the existence of calcification. In fact, in the hyperlipidemia groups (C, P and D), the correlation between IB values and stiffness was weak (r=0.51, p<0.01) (Fig 3D) , suggesting that atherosclerotic factors may influence the correlation between IB values and stiffness . A previous integrated backscatter analysis study 12 demonstrated that the carotid IB values increased in hypertension and showed a positive relationship with age in a healthy population, with those authors concluding that IB analysis was a useful noninvasive tool to detect vascular remodeling related to hypertension and aging. In the present study, the stiffness of carotid arteries also increased in proportion to aging (r=0.80, p<0.01), so the IB values of the carotid media must have a relation to the factors that increase with age.
It is known that the structure of the aortic media is closely related to the biomechanical tangential or circumferential strain resulting from intraluminal hydrostatic pressure. 13 Generally, elastin fibers maintain the elasticity and collagen fibers maintain the strength of arteries. In the present study, the IB values of carotid arterial media increased in proportion to stiffness , which suggests that the IB values reflect the structural properties of the vessel wall. However, histological studies are required to clarify this relationship.
In our previous study, the mean IB value of carotid artery media was 8.4±1.8 dB in vivo, 8 in contrast with the 12 dB recorded in the present study. However, most of the subjects in our previous study had end-stage of cancer and did not show significant atherosclerosis, so their IB values were unusually low compared with those of the present patients.
Different Effects of Statin Therapy on Medial IB Values
There are 2 types of statins: lipophilic (cerivastatin, simvastatin, lovastatin, fluvastatin and atorvastatin) and hydrophilic (pravastatin). Pravastatin is the only statin that is too hydrophilic to cross the cell membranes of nearly all tissues, including the vascular wall. Only liver cells possess active transport mechanisms for the uptake of this drug, whereas the disposition characteristics of cerivastatin result from its high hepatic extraction because of lipophilicity. 14 With respect to the APE on SMCs, the cerivastatin seems to be the most promising treatment because the effective dose range is 10-100-fold lower than other statins. 15, 16 Hydrophilic statins are distributed more selectively in hepatic cells than lipophilic statins and because the membrane of extrahepatic cells consists of lipid bilayers, hydrophilic statins cannot penetrate the cells and reach the cytoplasm, whereas lipophilic statins can enter both extrahepatic and hepatic cells. 17 In the present study, there was no effect of pravastatin on arterial medial sclerosis as assessed by IB values and stiffness , despite the fact that both cerivastatin and pravastatin satisfactorily decreased LDL-C, and that result is supported by previous findings that pravastatin did not induce significant changes in arterial diameter, distensibility or compliance of elastic and muscular large arteries. 18 Short-term therapy with pravastatin in mild to moderate hypercholesterolemia improved the lipid profile, but did not induce obvious changes in the functional properties of the large arteries. 18 Recently, a randomized trial demonstrated regression of IMT within 1 year in the setting of marked LDL-C reduction with 80 mg atorvastatin, compared with a more modest LDL-C reduction and stable IMT achieved with 40 mg pravastatin. 19 Another study using pravastatin found that IMT stabilized or slowed its progression, but regression was uncommon. 20 In the present study, IMT in the C and P groups did not show significant regression, which in the C group may have been related to shorter duration of therapy or lower dose than used in previous studies. Our results suggest that lipophilic statins such as cerivastatin have the potential to prevent adverse cardiovascular events on the basis of its effects on arterial stiffness.
Hydrophilic statins such as pravastatin have been definitively proven to reduce cardiovascular event rates 4, 21, 22 and so care must be exercised in the interpreting of the results of the present study. Pravastatin should not be considered inferior to lipophilic statins because it did not decrease IMT and arterial stiffness. However, cerivastatin did have an effect in reducing the stiffness of large arteries and may contribute to the prevention of peripheral arterial disease, cerebral arterial disease and hypertension, based on the relationship between IB values and aging. Although cerivastatin is no longer on the market because of some problematic side effects, it could be a potent cellular and molecular drug of the future. 23 
Study Limitations
We measured the IB values at one site of in the right common carotid artery and one site in the left common carotid artery in each patient, on the premise that the properties of the right and left sides differed. In the event that both have the same properties, the analyses may be statistically inaccurate. Second, there was no significant reduction of IMT, which may be related to the relatively short follow-up period and lower rate of LDL-C reduction in comparison with other large-scale studies. Furthermore, because of the small number of patients, analysis of the incidence of vascular events was not possible. Large-scale long-term studies, which include an analysis of the incidence of vascular events and stroke, are required.
Conclusions
There is an age-related increase in arterial stiffness, reflected by the IB values of the carotid media. Statin therapy with cerivastatin but not pravastatin significantly decreased the IB values of the carotid media and arterial stiffness. The difference between these 2 statins may be related to their effective dose range. The reduction in the IB values in response to cerivastatin suggests that this drug suppresses arterial wall dysfunction.
